Nat Goldhaber
Managing Director ...
Cureus is the medical journal for a new generation of both doctors AND patients. Leveraging the power of an online, crowd-sourced community platform, Cur?us promotes medical research by offering tools that better serve and highlight the people who create it, resulting in better research, faster publication and easier access for everyone.
DNAnexus - a pioneer in cloud-based solutions for large-scale DNA data management and analysis, was designed to accelerate basic science and clinical breakthroughs by providing a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The platform provides labs of any size a secure and compliant cloud platform that supports the unlimited scaling of computational and storage resources.
EcoFactor ’s automated energy management service can save 20-40% of HVAC energy use without sacrificing comfort, and gives utilities a more powerful and cost-effective tool for demand management.
Fluxion Biosciences has developed the revolutionary CellFlux microfluidics technology for conducting critical research and drug discovery at the cellular level. The CellFlux platform delivers a robust, high-performance, economical solution for single-cell analysis.
Genalyte has developed and is commercializing a laboratory protein and nucleic acid detection system based on revolutionary microring sensor technology. Unlike older systems, this new approach to biomarker detection uses a silicon chip containing arrays of photonic ring sensors that reduce or eliminate sample preparation and provide scalable multiplexing for both proteins and nucleic acids in rapid time periods. The one-step workflow of the system can deliver accurate results in as little as 10 minutes from small sample volumes. It has a large dynamic range and excellent sensitivity with outstanding reproducibility.
Natera is a leading genetic testing company in prenatal care, offering a simple, non-invasive and comprehensive maternal blood test to identify fetal genetic abnormalities. Natera provides a host of preconception and prenatal genetic testing services, including pre-implantation genetic diagnosis, carrier screening, screening of fetal chromosomal anomalies, and conception testing to understand cause of pregnancy loss after a miscarriage. What’s novel and unique is its proprietary bioinformatics-based technology (NATUS) to deliver accurate and comprehensive high-throughput testing for reproductive indications from tiny quantities of DNA.
Numedii, Inc. has developed IT technologies that scour enormous public and private drug and disease databases to unearth novel drug candidates that will have a higher probability of therapeutic success when incorporated into a pharmaceutical development plan. The company uses its Big Data technology to translate these novel disease-drug discoveries into new indications for existing drugs and optimal indications for drugs in development. The company partners with pharmaceutical companies for the clinical development and commercialization of its newly discovered drug candidates.
Renewable Funding develops innovative finance and technology solutions designed to transform America's economy to clean energy.
Trove (formerly Yerdle) is a people-powered store with the best prices on earth. Our inventory is the billions of useful items sitting idle in homes and storage spaces. On TROVE, you post items to earn credits and shop for what you want. Together, we make it easy to save money and reduce waste. Shop Freely!
